Identity, disability and the genome
By Felicity Boardman,
BioNews
| 04. 11. 2016
Untitled Document
In February 2016, the UK's first licence to use CRISPR/Cas9 genome-editing techniques in human embryo research was granted to Dr Kathy Niakan of the Francis Crick Institute, London (see BioNews 837). The decision sparked further debate on this controversial topic (see BioNews 833 and 836).
While the technology allows for precise 'editing' of the human genome at the single nucleotide level – signalling its potential to eradicate inheritable diseases – the attendant social, ethical and legal implications of the technology are complex. While the licence granted to Dr Niakan is limited (transfer of the edited embryos for gestation is strictly prohibited under its terms), the decision to grant the license in the first place was interpreted by some as the first step towards permitting so-called 'genetically modified' babies, as well as a permanent modification of the human germline.
Important questions have been raised, however, in the dialogue surrounding the licence application, particularly around how we understand and define identity, difference, as well as the nature and quality of human life.
Continue reading on BioNews...
Image via Muscular Dystrophy UK
Related Articles
By Emma McDonald Kennedy
| 09.25.2025
In the leadup to the 2024 election, Donald Trump repeatedly promised to make IVF more accessible. He made the commitment central to his campaign, even referring to himself as the “father of IVF.” In his first month in office, Trump issued an executive order promising to expand IVF access. The order set a 90-day deadline for policy recommendations for “lowering costs and reducing barriers to IVF,” although it didn’t make any substantive reproductive healthcare policy changes.
The response to the...
Sir Francis Galton, 1890s, by Eveleen Myers (née Tennant)
npg.org
Public Domain via Wikipedia
As has been discussed in recent issues of Biopolitical Times (1, 2), there are, increasingly, companies that claim to be selling parents better babies by selecting the “best” embryos. These services don’t come cheap – think $50,000, or even more, for embryo testing, plus perhaps as much again for IVF and concomitant services. To most of us, that is extremely expensive...
By Margaux MacColl, The San Francisco Standard | 09.17.2025
Designer babies are coming soon to an IVF clinic near you.
Nucleus Genomics, founded by Kian Sadeghi in 2020, when he was just 20, got its start analyzing genomes to weigh a person’s risk of everything from cancer to ADHD...
By Marianne Lamers, NEMO Kennislink [cites CGS' Katie Hasson] | 09.23.2025
Een rijtje gespreide vulva’s gaapt de bezoeker aan. Zó ziet een bevalling eruit, en zó een baarmoeder met foetus. Een zwangerschap, maar dan zonder zwangere vrouw, gestript van zorgen, gêne en pijn. De zwangerschapsmodellen en oefenbekkens, te zien in de...